Bonum Therapeutics Email Format

Biotechnology ResearchWashington, United States11-50 Employees

Bonum Therapeutics is a biotechnology research company based in Seattle, Washington. It focuses on regulating biological activity to create medicines that are conditionally active, aiming for high efficacy with reduced toxicity. The organization targets therapeutic areas where precisely controlled drug activity can improve safety and outcomes, addressing needs in the broader biopharma landscape that seeks more selective and tolerable treatments. Positioned within the biotechnology research sector, Bonum Therapeutics emphasizes a technology approach centered on regulation to modulate drug effects. The company operates in a regional ecosystem around Seattle and maintains a relatively small to mid-sized team, reflecting its early-stage development profile. A notable recent development is the announcement of a Series A financing round in 2022, signaling external validation and progress in its pursuit of its regulatory-based therapeutic concepts.

Sign up for free to view info

Company overview Employee directory